Applied UV, Inc.
(NASDAQ:AUVI)
Innovations for Infection Prevention
J U L Y 2 0 2 1
www.applieduvinc.com
Safe Harbor Statement
This presentation may contain "forward-looking statements." Forward-looking statements reflect the current view about future
events. When used in this prospectus, the words "anticipate," "believe," "estimate," "expect," "future," "intend," "plan," or the negative of these terms and similar expressions, as they relate to us or our management, identify forward-looking statements. Such statements, include, but are not limited to, statements contained in this presentation relating to the view of management of Applied UV, Inc. (the "Company") concerning its business strategy, future operating results and liquidity and capital resources outlook. Forward-looking statements are based on the Company's current expectations and assumptions regarding its business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. The Company's actual results may differ materially from those contemplated by the forward-looking statements. They are neither statements of historical fact nor guarantees of assurance of future performance. We caution you therefore against relying on any of these forward-looking statements. Factors or events that could cause the Company's actual results to differ may emerge from time to time, and it is not possible for the Company to predict all of them. The Company cannot guarantee future results, levels of activity, performance or achievements. Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to actual results.
© Copyright 2021 Applied UV, Inc. | All Rights Reserved | 2
Corporate Overview
Applied UV offers lab validated, data driven disinfection solutions for air and surface applications.
Air Purification
Eliminates:
FDA Cleared Medical Device (Class II)
Suitable for providing medical grade air purification in
critical hospital settings
© Copyright 2021 Applied UV, Inc. | All Rights Reserved | 3
Recent Airocide Agreements & Purchase Orders
2020
2020 Revenue
$4.4M
Installed Airocide
at Fenway Park
and Jet Blue Park
~$700k
March
2021
Exclusive Distribution | 60 Units installed |
Agreement for African | in a school in |
continent | Uruguay |
$3.5M minimum | ~$100k |
Over 1 Year | |
MayJune
Miscellaneous significant orders with new & potential new distributors:
- Scandinavia
- Hungary
- Vietnam
- Japan
~350k
Q2 -2021
© Copyright 2021 Applied UV, Inc. | All Rights Reserved | 4
Milestones
Q1 - 2021
Partner with
Boston Red Sox to install Airocide at Fenway Park and Jet Blue Park
Q2 - 2021
Partner with
Denver Art
Museum & | |
Arapahoe County | |
Sign exclusive | Library tests |
partnership
agreement for
Africa with 3Sixty in
Africa
Announce Program with expansion to other urban schools in Uruguay
Q3 - 2021
Launch Airocide Aria Consumer model and website for D2C fulfillment
Announce
additional sales
with public sports arenas as economy opens wider
Q4 - 2021
Mt. Sinai publishes results of clinical evaluation of our UVC disinfecting system
Acquire Airocide Technology Platform
© Copyright 2021 Applied UV, Inc. | All Rights Reserved | 5
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original document
- Permalink
Disclaimer
Applied UV Inc. published this content on 30 June 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 June 2021 15:09:22 UTC.